Compile Data Set for Download or QSAR
Report error Found 1591 of ic50 data for polymerid = 3678,50001681
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM689029(US20240190890, Compound I-255 | (S)-10-(fluorometh...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50348545(CHEMBL1801384)
Affinity DataIC50: 1nMAssay Description:Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM689029(US20240190890, Compound I-255 | (S)-10-(fluorometh...)
Affinity DataIC50: 1nMAssay Description:Inhibition of MK2 (unknown origin) using ST3-Sox peptide as substrate measured for 120 mins in presence of ATP by Synergy H4 plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688793(US20240190890, Compound I-13 | (R)-3-(2-(methoxyme...)
Affinity DataIC50: 1nMAssay Description:Inhibition of MK2 (unknown origin) using ST3-Sox peptide as substrate measured for 120 mins in presence of ATP by Synergy H4 plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688944(US20240190890, Compound I-164 | (R)-10-methyl-3-(2...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 1nMAssay Description:Inhibition of human MAPKAPK2 using KKLNRTLSVA as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688835(US20240190890, Compound I-55 | (R)-10-methyl-3-(2-...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50297122((R)-10-Methyl-9,10,11,12-tetrahydro-7-thia-4,9,12-...)
Affinity DataIC50: 1nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688784(US20240190890, Compound I-4 | (R)-3-(2-chloro-5-(t...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688793(US20240190890, Compound I-13 | (R)-3-(2-(methoxyme...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688856(US20240190890, Compound I-76 | (R)-3-(2-(hydroxyme...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688858(US20240190890, Compound I-78 | (R)-3-(6-ethynyl-2-...)
Affinity DataIC50: 1nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50434486(CHEMBL2385548)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688802(US20240190890, Compound I-22 | (R)-3-(2-(ethoxymet...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688993(US20240190890, Compound I-214 | (R)-10-methyl-3-(5...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50374681(CHEMBL257834)
Affinity DataIC50: 2nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50374682(CHEMBL403154)
Affinity DataIC50: 2nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50374683(CHEMBL258045)
Affinity DataIC50: 2nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688941(US20240190890, Compound I-161 | (R)-4-(10-methyl-8...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688879(US20240190890, Compound I-99 | (R)-3-(2-(hydroxyme...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50395272(CHEMBL1231206)
Affinity DataIC50: 2nMAssay Description:Inhibition of human MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688942(US20240190890, Compound I-162 | (R)-6-ethynyl-4-(1...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688905(US20240190890, Compound I-125 | (R)-10-methyl-3-(2...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50374681(CHEMBL257834)
Affinity DataIC50: 2nMAssay Description:Inhibition of human MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM689002(US20240190890, Compound I-224 | (R)-10-methyl-3-(3...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688919(US20240190890, Compound I-139 | (R)-10-methyl-3-(6...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688791(US20240190890, Compound I-11 | (R)-3-(6-chloropyri...)
Affinity DataIC50: 2nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50297124((R)-3-Chloro-10-methyl-9,10,11,12-tetrahydro-7-thi...)
Affinity DataIC50: 2nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2010
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688919(US20240190890, Compound I-139 | (R)-10-methyl-3-(6...)
Affinity DataIC50: 2nMAssay Description:Inhibition of MK2 (unknown origin) using ST3-Sox peptide as substrate measured for 120 mins in presence of ATP by Synergy H4 plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50362173(CHEMBL1938685)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in da...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688839(US20240190890, Compound I-59 | (R)-3-(6-ethynyl-2-...)
Affinity DataIC50: 3nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50374679(CHEMBL403258)
Affinity DataIC50: 3nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688940(US20240190890, Compound I-160 | (R)-6-chloro-4-(10...)
Affinity DataIC50: 3nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688911(US20240190890, Compound I-131 | (R)-10-methyl-3-(2...)
Affinity DataIC50: 3nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50465454(CHEMBL4293121)
Affinity DataIC50: 3nMAssay Description:Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688917(US20240190890, Compound I-137 | methyl (R)-4-(10-m...)
Affinity DataIC50: 3nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50465455(CHEMBL4282514)
Affinity DataIC50: 3nMAssay Description:Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50465453(CHEMBL4277929)
Affinity DataIC50: 3nMAssay Description:Inhibition of human MK2 using hsp27 peptide biotinyl-AYSRALSRQLSSGVSEIRCOOH as substrate after 45 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688839(US20240190890, Compound I-59 | (R)-3-(6-ethynyl-2-...)
Affinity DataIC50: 3nMAssay Description:Inhibition of MK2 (unknown origin) using ST3-Sox peptide as substrate measured for 120 mins in presence of ATP by Synergy H4 plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688831(US20240190890, Compound I-51 | (R)-3-(6-ethynylpyr...)
Affinity DataIC50: 3nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50374687(CHEMBL256194)
Affinity DataIC50: 3nMAssay Description:Inhibition of MK2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50434488(CHEMBL2385549)
Affinity DataIC50: 3nMAssay Description:Inhibition of MK2 (unknown origin) phosphorylation using TAMRA labeled peptide as substrate incubated 30 mins before substrate addition measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50348515(CHEMBL1233942)
Affinity DataIC50: 3nMAssay Description:Inhibition of MK2 mediated anisomycin-stimulated hsp27 phosphorylation in human THP-1 cells by fluorometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50362175(CHEMBL1938687)
Affinity DataIC50: 3.80nMAssay Description:Inhibition of MK2 using TAMRA-labeled peptide as substrate pre-incubated for 30 mins prior substrate addition measured after 30 mins incubation in da...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2012
Entry Details Article
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688854(US20240190890, Compound I-74 | (R)-3-(6-chloro-2-(...)
Affinity DataIC50: 4nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688985(US20240190890, Compound I-206 | (R)-10-methyl-3-(4...)
Affinity DataIC50: 4nMAssay Description:Inhibition of MK2 (unknown origin) using ST3-Sox peptide as substrate measured for 120 mins in presence of ATP by Synergy H4 plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688798(US20240190890, Compound I-18 | (R)-10-methyl-3-(6-...)
Affinity DataIC50: 4nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688844(US20240190890, Compound I-64 | (R)-3-(2-(3-amino-3...)
Affinity DataIC50: 4nMAssay Description:Inhibition of MK2 (unknown origin) using ST3-Sox peptide as substrate measured for 120 mins in presence of ATP by Synergy H4 plate reader analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688889(US20240190890, Compound I-142 | (R)-10-methyl-3-(5...)
Affinity DataIC50: 4nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM688799(US20240190890, Compound I-19 | (R)-10-methyl-3-(2-...)
Affinity DataIC50: 4nMAssay Description:Briefly, 10× stock solutions of MK2 (PV3317, from Life Technologies), 1.13X ATP (AS001A), and Sox conjugated peptide substrate, S/T3-Sox, (KZN1031) w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 1591 total ) | Next | Last >>
Jump to: